Abstract
We investigated the eicosanoid synthesis of platelets of Wistar and of Okamoto spontaneously hypertensive rats (SHR), and the effect of captopril in vitro, using [14C]arachidonic acid as a tracer substrate and chromatographic determination. Lipoxygenase activity was elevated, while the formation of cyclooxygenase products was reduced in SHR platelets, compared to those of Wistar rats. This difference might play a role in the pathomechanism of hypertension in SHR. In SHR with lower blood pressure, captopril reduced thromboxane synthesis, while in SHR with higher blood pressure thromboxane synthesis was unchanged, but the synthesis of prostaglandin D2, a potent vasodilator, and of 12-L-hydroxy-5,8,10-heptadecatrienoic acid, a stimulator of endothelial prostacyclin formation, was increased. We may conclude that, in spite of the missing angiotensin converting enzyme in platelets, a direct effect on platelet eicosanoid synthesis could contribute to the blood pressure decreasing effect of captopril.
References
Sep 1, 1975·Analytical Biochemistry·H C KieferH S Kantor
Sep 1, 1992·Prostaglandins·C LemneU de Faire
Jan 15, 1991·Clinica Chimica Acta; International Journal of Clinical Chemistry·S L ScharpéA Yaron
Jan 1, 1991·Clinical and Experimental Hypertension. Part A, Theory and Practice·M W ChapleauF M Abboud
Aug 1, 1991·Hypertension·L Lin, A Nasjletti
May 12, 1986·Biochimica Et Biophysica Acta·R A Snyder, B U Wintroub
Mar 11, 1988·The American Journal of Medicine·A SantucciF Balsano
Nov 1, 1987·Prostaglandins·P D SadowitzM Stuart
Nov 1, 1987·The American Journal of Cardiology·V J Dzau, S L Swartz
Apr 21, 1982·The American Journal of Cardiology·S L Swartz, G H Williams
Aug 5, 1983·European Journal of Pharmacology·R DüsingH J Kramer
Jan 1, 1983·Cardiology·K SilberbauerH Sinzinger
Jun 1, 1983·Prostaglandins·G S Lewis, R A Waterman
Feb 1, 1980·Prostaglandins·M S Abdel-HalimE Anggård
May 1, 1980·Clinical Pharmacology and Therapeutics·K J KripalaniB H Migdalof
Dec 1, 1980·Clinical Science·K AbeK Yoshinaga
Jun 1, 1982·Clinical Science·H WitzgallP C Weber
Apr 1, 1980·Biopharmaceutics & Drug Disposition·J J MackichanW J Jusko
Jul 1, 1995·Blood Pressure·I F IslimD G Beevers
Jan 1, 1993·Journal of Cardiovascular Pharmacology·P M VanhoutteJ V Mombouli
May 1, 1994·Blood Pressure·S E KjeldsenS Julius
Jan 1, 1993·Life Sciences· Huzoor-AkbarR Kornhauser
Jan 1, 1993·Journal of Tongji Medical University = Tong Ji Yi Ke Da Xue Xue Bao·D W WangZ D Deng
Dec 1, 1993·Thrombosis Research·S NityanandB N Singh
Nov 1, 1993·Journal of the American Society of Nephrology : JASN·S R SmithL P Svetkey
May 1, 1993·Journal of Hypertension·M Ishida-KainouchiT Oshima
Aug 1, 1993·British Journal of Pharmacology·M Schirner, C Taube
May 1, 1993·Clinical and Experimental Hypertension : CHE·J M KrzesinskiG Rorive
May 1, 1996·Hypertension·N SternE Knoll
Mar 1, 1963·Japanese Circulation Journal·K OKAMOTO, K AOKI
Nov 18, 2008·Cancer Research·Jessica L FlemingAmanda Ewart Toland
Citations
Mar 30, 1999·European Journal of Pharmacology·B KisM A Deli
Jan 29, 2000·European Journal of Pharmacology·Z SzuperaG Telegdy
Nov 24, 1999·Prostaglandins & Other Lipid Mediators·B KisG Telegdy
Nov 7, 2000·Drug and Alcohol Dependence·A MargolinL Grupp
Feb 5, 1999·Biochimica Et Biophysica Acta·D J HillA F Rowley
Oct 16, 1999·Acta Physiologica Scandinavica·B KisG Telegdy
Mar 18, 1999·Epilepsia·B KisL Vécsei
Oct 27, 2021·Platelets·Sándor VácziZ Mezei